RE:RE:P/S around 25 Well, let's see what happened in the last quarter:
Recreational cannabis revenue, the biggest portion of CGC’s revenue, fell 11% from $68.9 million CAD to $61 million CAD. Even though medical and international sales rose during the quarter, total gross revenue fell 2.9%.
Total sales in volume terms (kilograms and equivalents) rose 13%. Total sales volume was 10,549 kilograms and equivalents in the latest quarter against 9,326 kilograms in the prior quarter. Comparing the June quarter with the December quarter, volume increased only 4.4%.
So that means the effective cannabis price fell this quarter. They sold 13% more product and the gross revenue fall by 2.9%.
After the acquisitions, the adjusted FCF widened to loss of $824 million CAD from a loss of $414 million CAD. This is an increase in adjusted-FCF losses of 99%.
If CGC keeps losing $824 million CAD each quarter, the billions you depend on will be mostly spent BEFORE the next year end.
Therefore, your ignorance is at least remarkable.